HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

IL-15 preferentially enhances functional properties and antigen-specific responses of CD4+CD28(null) compared to CD4+CD28+ T cells.

Abstract
One of the most prominent changes during T-cell aging in humans is the accumulation of CD28(null) T cells, mainly CD8+ and also CD4+ T cells. Enhancing the functional properties of these cells may be important as they provide an antigen-specific defense against chronic infections. Recent studies have shown that IL-15 does in fact play an appreciable role in CD4 memory T cells under physiological conditions. We found that treatment with IL-15 increased the frequency of elderly CD4+CD28(null) T cells by the preferential proliferation of these cells compared to CD4+CD28+ T cells. IL-15 induced an activated phenotype in CD4+CD28(null) T cells. Although the surface expression of IL-15R α-chain was not increased, the transcription factor STAT-5 was preferentially activated. IL-15 augmented the cytotoxic properties of CD4+CD28(null) T cells by increasing both the mRNA transcription and storage of granzyme B and perforin for the cytolytic effector functions. Moreover, pretreatment of CD4+CD28(null) T cells with IL-15 displayed a synergistic effect on the IFN-γ production in CMV-specific responses, which was not observed in CD4+CD28+ T cells. IL-15 could play a role enhancing the effector response of CD4+CD28(null) T cells against their specific chronic antigens.
AuthorsRebeca Alonso-Arias, Marco A Moro-García, José R Vidal-Castiñeira, Juan J Solano-Jaurrieta, Francisco M Suárez-García, Eliecer Coto, Carlos López-Larrea
JournalAging cell (Aging Cell) Vol. 10 Issue 5 Pg. 844-52 (Oct 2011) ISSN: 1474-9726 [Electronic] England
PMID21635686 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2011 The Authors. Aging Cell © 2011 Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland.
Chemical References
  • Antibodies, Viral
  • Biomarkers
  • CD28 Antigens
  • Interleukin-15
  • RNA, Messenger
  • Recombinant Proteins
  • STAT5 Transcription Factor
  • Perforin
  • Interferon-gamma
  • Granzymes
Topics
  • Aged
  • Aged, 80 and over
  • Antibodies, Viral (analysis)
  • Biomarkers
  • CD28 Antigens (analysis, immunology)
  • CD4-Positive T-Lymphocytes (drug effects, immunology)
  • CD8-Positive T-Lymphocytes (drug effects, immunology)
  • Cell Proliferation
  • Cytomegalovirus (immunology)
  • Granzymes (metabolism)
  • Humans
  • Interferon-gamma (immunology, metabolism)
  • Interleukin-15 (immunology, pharmacology)
  • Leukocytes, Mononuclear (drug effects, immunology)
  • Lymphocyte Activation
  • Perforin (metabolism)
  • RNA, Messenger (genetics, metabolism)
  • Recombinant Proteins (immunology, pharmacology)
  • STAT5 Transcription Factor (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: